Latest Bevacizumab Stories
A new approach to treating advanced ovarian cancer may significantly improve patients’ survival compared to standard chemotherapy regimens, according to results published online today as the
DALLAS, March 19, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Lucentis (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023" market research
RnRMarketResearch.com adds “Avastin (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023” to its store. Dallas, Texas (PRWEB)
SYDNEY, March 17, 2015 /PRNewswire/ -- - In the first-line treatment of non-resectable metastatic colorectal cancer: - SIRFLOX study
SAN DIEGO, March 16, 2015 /PRNewswire/ -- Gensignia Life Sciences, Inc., (Gensignia) a molecular diagnostics company specializing in microRNA (miRNA) signatures as cancer diagnostic
Close competition encourages established manufacturers to broaden the drug pipeline for targeted therapies, finds Frost & Sullivan LONDON, March 3, 2015 /PRNewswire/ -- Although lung
DALLAS, March 2, 2015 /PRNewswire/ -- ReportsnReports.com adds Lonsurf and Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 research report focuses on
The two halves of the human colon have different embryonic origins and gene expression patterns, and these differences may also play a role in cancer biology, according to a study published February
In patients with moderate or worse vision loss at baseline, those treated with EYLEA gained, on average, an additional full line or more on an eye chart when compared to those treated with alternative
CALGARY, Feb. 18, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
- An armed gangster.